Taking the STING Out of Cancer: Discovery about How Cancer Cells Evade Immune Defenses Inspires New Treatment Approach
The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability.
Roundup
Top 10 Stories of 2018, Cancer Research Edition
Take a look back at some of the year’s biggest news in cancer research.
Samuel Bakhoum Awarded 2018 NIH Early Independence Award
Sam Bakhoum, MD, PhD, Assistant Attending in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center (MSK), has been named a winner of the 2018 National Institutes of Health Director’s Early Independence Award, which is provided by the NIH Common Fund’s High-Risk, High-Reward Research program. This award is given to exceptional scientists who have contributed significant work in biomedical research.
In the Lab
Putting the STING in Immunotherapy: Research Focuses on Ways to Improve Cancer Treatments
Researchers are looking for ways to make cancer cells more visible to the immune system.
In the Lab
Escape Artists: Cancer Cells Mimic Immune Cell Activity to Spread
Researchers have discovered that cancer cells may hijack an immune response to spread from a primary tumor to distant organs.
At Work: Radiation Oncologist and Breast Cancer Specialist Samuel Bakhoum
Samuel Bakhoum is a physician-scientist who studies chromosomal instability and its role in how cancer grow and spreads.
